News
View recent announcements and news releases related to Providence Research
To read the full article, please click on the article title.How COVID-19 damages your heart
By Grace Jenkins
A study from the Centre for Heart Lung Innovation at St. Paul’s Hospital characterised the collage of ways COVID-19 damages the heart in a manner unique from other viruses.
Trends in pre-Exposure prophylaxis (PrEP) use in nine Canadian provinces, 2018 - 2021
Patients may be at higher risk of overdose when opioid therapy for pain is discontinued
Study suggests enhanced guidance for opioid prescribing needed to manage pain, reduce risk of overdose
Discontinuing opioids prescribed for chronic pain was associated with increased risk of overdose, according to a new study from the BC Centre on Substance Use and University of British Columbia-Okanagan published today in PLOS Medicine.
SinoNasal Microbiota Transfer (SNMT) Trial to Treat Chronic Rhinosinusitis Underway
A clinical trial, “SinoNasal Microbiota Transfer (SNMT) to treat chronic rhinosinusitis: A randomized, double-blind, placebo-controlled trial,” is currently being conducted.
This trial is being run by Dr. Amin Javer at the St. Paul’s Sinus Centre and Dr. Amee Manges with UBC and the B.C. Centre for Disease Control. Other collaborators on this trial are Dr. Andrew Thamboo and Dr. Joel Singer.
Looking Back on Skunkworks: Hacking Wounds
A unique innovation event designed to tackle the challenges faced by patients and communities when dealing with wounds, both in Canada and around the globe, brought together a diverse group of people to find solutions to this significant health issue.
Long COVID patients show signs of autoimmune disease a year after infection
Blood samples from patients with long COVID who are still suffering from fatigue and shortness of breath after a year show signs of autoimmune disease, according to a study published today (Thursday) in the European Respiratory Journal [1].
Autoimmune disease occurs when the immune system mistakenly attacks healthy parts of the body, instead of defending the body against disease. It causes conditions such as rheumatoid arthritis and lupus.
Knowledge Translation Challenge 2022 announces funding for eight teams, including two at PHC
AGGIE BLACK
DIRECTOR, HEALTH SERVICES & CLINICAL RESEARCH AND KNOWLEDGE TRANSLATION
August 2, 2022
The Knowledge Translation Challenge is an annual program run in collaboration between Providence Health Care, Vancouver Coastal Health Research Institute and BC Cancer, using a comprehensive approach that combines training, mentoring and funding to help clinicians build skills and confidence to identify, implement, and evaluate evidence- informed practice improvements.
Program Director Update
I am pleased to announce that Julie Lajeunesse has accepted the Program Director, Urban Health & Substance Use role as Scott Harrison continues on his LTD. Over the last three years, Julie has been the Program Director for Renal and will continue to support this team while work continues on the realignment of the leadership structure in preparation for the New St. Paul’s Hospital.
Innovators unite! New innovation focus bubbling up at Providence
Innovarium 360° is the name of our “innovation ecosystem." Think of it as the glue or connective tissue between the various components of PHC, providing cohesion and internal support for improvements, advancements and new ways of doing things.
Congratulations to this year’s UBC’s Faculty of Medicine Distinguished Achievement Award Winners who practice at Providence Research and St. Paul’s Hospital
June 27, 2022, Vancouver, BC – Dr. Darryl Knight, President, Providence Research, Vice President, Research & Academic Affairs, Providence Health Care (PHC) and Associate Dean - Research, Faculty of Medicine, University of British Columbia (UBC) would like to congratulate the University of British Columbia’s, 2022 Faculty of Medicine Distinguished Achievement Award Recipients who received recognition for their efforts in advancing health care.
Pages